Table 1 Patient demographics
Variable | No. of patients (%) |
|---|---|
Enrolled | 27 (100) |
Assessable | 25 (93) |
Median age | 63 (range, 38–74) |
Gender | |
Male | 16 (59) |
Female | 11 (41) |
Performance status (ECOG) | |
Median | 1 |
0 | 1 (4) |
1 | 17 (63) |
2 | 9 (33) |
Tumor origin | |
Pancreatic cancer | 12 (44) |
Gastric cancer | 11 (41) |
Cholangiocarcinoma | 3 (11) |
Cancer of unknown primary (adenocarcinoma) | 1 (4) |
Prior chemotherapy | |
None (gastric cancer) | 10 (37) |
One line | 13 (48) |
Two lines | 4 (15) |
Gemcitabine | 15 (56) |
5-fluorouracil-based (i.v. or oral) | 8 (30) |
Others (irinotecan, oxaliplatin) | 2 (7) |
Tumor localisation | |
Primary | 19 (70) |
Liver | 17 (63) |
Lymph nodes | 6 (22) |
Peritoneal carcinomatosis | 10 (37) |
Other | 2 (7) |
